Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Careium reports robust Q3 growth, B3 revises '25 targets amid declining utilization rate

EditorRachael Rajan
Published 2023-10-26, 03:00 p/m
© Reuters.
CAREI
-

In the third quarter of 2023, Careium posted a 1% increase in sales, reaching SEK 217.3m ($24.7m), surpassing the projected SEK 215m ($24.4m). This growth, marking an impressive 23.5% year-on-year organic increase excluding foreign exchange influences, was largely driven by a net gain in service contracts and a surge in hardware demand in the Nordics, Germany, and France. The product sales for the quarter amounted to SEK 58.1m while service sales stood at SEK 159.3m.

The company also reported a substantial 53% jump in EBIT, which reached SEK 20.7m, far exceeding the expected SEK 13.5m and yielding an EBIT margin of 9.5%. This significant progress was primarily attributed to efficiency improvements, lower delivery costs, and foreign exchange tailwinds involving GBP and USD currencies. The gross margin rose to 43.5%, with operating expenses slightly decreasing to SEK -73.9m. As per pre-Q3 estimates, Careium's shares are trading at a multiple of 5.3x '24e EV/EBITA.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.